Picture of Avalo Therapeutics logo

AVTX — Avalo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Avalo Therapeutics Inc Delivered Written Notice To Cantor Fitzgerald & Co. & RBC Capital Markets, Llc To Terminate Sales Agreement

April 21 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO THERAPEUTICS INC - ON APRIL 20 DELIVERED WRITTEN
NOTICE TO
CANTOR FITZGERALD & CO. & RBC CAPITAL MARKETS, LLC TO TERMINATE
SALES AGREEMENT
    * AVALO THERAPEUTICS INC - DELIVERED WRITTEN NOTICE TO
CANTOR &
RBC TO TERMINATE SALES AGREEMENT, EFFECTIVE NO LATER THAN APRIL
30, 2023
    * AVALO THERAPEUTICS INC -  IS NOT SUBJECT TO ANY
TERMINATION
PENALTIES RELATED TO TERMINATION OF THE SALES AGREEMENT


Further company coverage:  AVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Avalo Therapeutics

See all news